Literature DB >> 22310551

Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.

Sigurdur Y Kristinsson1, Lynn R Goldin, Ingemar Turesson, Magnus Björkholm, Ola Landgren.   

Abstract

Lymphoplasmacytic lymphoma (LPL)/Waldenström macroglobulinemia (WM) is a B-cell disorder resulting from the accumulation, predominantly in the bone marrow, of clonally related lymphoplasmacytic cells. LPL/WM is a very rare disease, with an incidence rate of 3-4 cases per million people per year.Currently, the causes of LPL/WM are poorly understood; however, there are emerging data to support a role for immune-related factors in the pathogenesis of LPL/WM. In addition, data show that genetic factors are of importance in the etiology of LPL/WM. In this paper, we will review the current knowledge about familiality of LPL/WM and provide novel data on solid tumors and myeloid malignancies in first-degree relatives of LPL/WM patients.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22310551      PMCID: PMC3326274          DOI: 10.1159/000335618

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  23 in total

1.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

Authors:  Tom Vulliamy; Anna Marrone; Richard Szydlo; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

2.  Methods for testing familial aggregation of diseases in population-based samples: application to Hodgkin lymphoma in Swedish registry data.

Authors:  R M Pfeiffer; L R Goldin; N Chatterjee; S Daugherty; K Hemminki; D Pee; L I X; M H Gail
Journal:  Ann Hum Genet       Date:  2004-09       Impact factor: 1.670

3.  Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasms.

Authors:  A Altieri; J L Bermejo; K Hemminki
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

4.  Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples.

Authors:  Lynn R Goldin; Ola Landgren; Mary L McMaster; Gloria Gridley; Kari Hemminki; Xinjun Li; Lene Mellemkjaer; Jørgen H Olsen; Martha S Linet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

5.  Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia.

Authors:  Matthew F Rudd; Gabrielle S Sellick; Emily L Webb; Daniel Catovsky; Richard S Houlston
Journal:  Blood       Date:  2006-03-30       Impact factor: 22.113

6.  Characterization of familial Waldenstrom's macroglobulinemia.

Authors:  S P Treon; Z R Hunter; A Aggarwal; E P Ewen; S Masota; C Lee; D Ditzel Santos; E Hatjiharissi; L Xu; X Leleu; O Tournilhac; C J Patterson; R Manning; A R Branagan; C C Morton
Journal:  Ann Oncol       Date:  2005-12-15       Impact factor: 32.976

7.  Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation.

Authors:  Regan H Royer; Jill Koshiol; Therese R Giambarresi; Linda G Vasquez; Ruth M Pfeiffer; Mary L McMaster
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

8.  Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994.

Authors:  F D Groves; L B Travis; S S Devesa; L A Ries; J F Fraumeni
Journal:  Cancer       Date:  1998-03-15       Impact factor: 6.860

9.  A case-control and family study of Waldenstrom's macroglobulinemia.

Authors:  M S Linet; R L Humphrey; E S Mehl; L M Brown; L M Pottern; W B Bias; L McCaffrey
Journal:  Leukemia       Date:  1993-09       Impact factor: 11.528

10.  Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Xinjun Li; Kari Hemminki
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

View more
  4 in total

Review 1.  Familial leukemias.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2015-02

Review 2.  Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.

Authors:  Prashant Kapoor; Jonas Paludo; Stephen M Ansell
Journal:  Curr Treat Options Oncol       Date:  2016-03

Review 3.  Waldenstrom's Macroglobulinemia: An Update.

Authors:  Maddalena Mazzucchelli; Anna Maria Frustaci; Marina Deodato; Roberto Cairoli; Alessandra Tedeschi
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

4.  Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study.

Authors:  Seri Jeong; Seom Gim Kong; Da Jung Kim; Sangjin Lee; Ho Sup Lee
Journal:  BMC Cancer       Date:  2020-07-03       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.